Micro-filament Intracranial Recording for Epilepsy
(NeuroSeizure Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to record brain activity in individuals with epilepsy that does not respond to standard treatments. Researchers use special electrodes, known as Macro-micro Tetrodes, to better identify the brain areas causing seizures and understand brain circuit function during these episodes. The trial includes individuals diagnosed with refractory epilepsy who qualify for a brain recording procedure called sEEG, which measures electrical activity in the brain. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to new insights and treatments for epilepsy.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on anti-thrombotic treatment (medications that prevent blood clots), you may not be eligible to participate.
What prior data suggests that these macro-micro tetrodes are safe for intracranial use?
Research has shown that using special electrodes for brain recordings in epilepsy patients is generally safe. These electrodes, called macro-micro tetrodes, have a safety record similar to standard ones. The risk of complications is low, with few serious side effects reported. Most people tolerate them well, making them a promising option for studying brain activity in epilepsy without adding significant risk.12345
Why are researchers excited about this trial?
Researchers are excited about using macro-micro tetrodes for epilepsy because this approach offers a more detailed way to monitor brain activity. Unlike standard macroelectrodes, which provide a broader overview, these novel micro-macroelectrodes allow for more precise and localized recording of neuronal signals. This enhanced precision could lead to better-targeted treatments and potentially improve outcomes for patients with epilepsy by identifying seizure foci more accurately.
What evidence suggests that these macro-micro tetrodes are effective for epilepsy?
Previous studies have successfully used special electrodes called hybrid electrodes with tetrodes to record brain activity in people with epilepsy, providing high-quality data. Research shows these electrodes can detect fast ripples, tiny brain waves linked to seizure origins. This capability might help doctors pinpoint the exact brain area causing seizures. In this trial, participants will receive implants of novel intracerebral micro-macroelectrodes, shown to be as safe and effective as standard electrodes for monitoring brain activity. This technology offers a better understanding of brain activity related to epilepsy, potentially leading to improved treatments.12346
Are You a Good Fit for This Trial?
This trial is for individuals with refractory epilepsy who are eligible for a special brain monitoring procedure called sEEG. It's not suitable for those with severe psychiatric issues, intense agitation during seizures, or conditions that prevent MRI scans like claustrophobia or certain implants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implantation and Monitoring
Patients are implanted with novel intracerebral micro-macroelectrodes to record fast ripples and single neuron activity
Assessment
Evaluate the efficiency of microelectrodes compared to macroelectrodes in recording fast ripples
Follow-up
Participants are monitored for safety and effectiveness after the implantation and assessment phases
What Are the Treatments Tested in This Trial?
Interventions
- Macro-micro Tetrodes
Macro-micro Tetrodes is already approved in European Union, United States for the following indications:
- Epilepsy diagnosis
- Epileptogenic zone identification
- Research use in epilepsy
- Investigational device for EZ identification
Find a Clinic Near You
Who Is Running the Clinical Trial?
Adrien Peyrache
Lead Sponsor
McGill University
Lead Sponsor